333 related articles for article (PubMed ID: 26123797)
1. Polycystic ovary syndrome: cardiovascular risk factors according to specific phenotypes.
Aziz M; Sidelmann JJ; Faber J; Wissing ML; Naver KV; Mikkelsen AL; Nilas L; Skouby SO
Acta Obstet Gynecol Scand; 2015 Oct; 94(10):1082-9. PubMed ID: 26123797
[TBL] [Abstract][Full Text] [Related]
2. Endogenous thrombin potential in polycystic ovary syndrome: the association to body mass index, insulin resistance, and inflammation.
Aziz M; Sidelmann JJ; Wissing ML; Faber J; Skouby SO
Gynecol Endocrinol; 2015; 31(9):720-4. PubMed ID: 26291802
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
4. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
5. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
Moran LJ; Hutchison SK; Meyer C; Zoungas S; Teede HJ
Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome and low-grade inflammation with special reference to YKL-40.
Aziz M; Wissing ML; Naver KV; Faber J; Skouby SO
Gynecol Endocrinol; 2014 Apr; 30(4):311-5. PubMed ID: 24471491
[TBL] [Abstract][Full Text] [Related]
9. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
[TBL] [Abstract][Full Text] [Related]
10. Vascular function in the diagnostic categories of polycystic ovary syndrome.
Moran LJ; Cameron JD; Strauss BJ; Teede HJ
Hum Reprod; 2011 Aug; 26(8):2192-9. PubMed ID: 21616917
[TBL] [Abstract][Full Text] [Related]
11. Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.
Koiou E; Tziomalos K; Dinas K; Katsikis I; Kandaraki EA; Tsourdi E; Mavridis S; Panidis D
Endocr J; 2012; 59(1):21-9. PubMed ID: 21996594
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
Tarkun I; Arslan BC; Cantürk Z; Türemen E; Sahin T; Duman C
J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
[TBL] [Abstract][Full Text] [Related]
13. The impact of body mass on inflammatory markers and insulin resistance in polycystic ovary syndrome.
Souza Dos Santos AC; Soares NP; Costa EC; de Sá JC; Azevedo GD; Lemos TM
Gynecol Endocrinol; 2015 Mar; 31(3):225-8. PubMed ID: 25373529
[TBL] [Abstract][Full Text] [Related]
14. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
15. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
Thomson RL; Buckley JD; Moran LJ; Noakes M; Clifton PM; Norman RJ; Brinkworth GD
BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
[TBL] [Abstract][Full Text] [Related]
16. A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome.
Kelly CJ; Lyall H; Petrie JR; Gould GW; Connell JM; Rumley A; Lowe GD; Sattar N
J Clin Endocrinol Metab; 2002 Jul; 87(7):3287-90. PubMed ID: 12107238
[TBL] [Abstract][Full Text] [Related]
17. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome.
Mannerås-Holm L; Baghaei F; Holm G; Janson PO; Ohlsson C; Lönn M; Stener-Victorin E
J Clin Endocrinol Metab; 2011 Apr; 96(4):1068-76. PubMed ID: 21252248
[TBL] [Abstract][Full Text] [Related]
18. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
Graff SK; Mário FM; Alves BC; Spritzer PM
Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
[TBL] [Abstract][Full Text] [Related]
19. Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.
Kaya C; Pabuccu R; Berker B; Satiroglu H
Fertil Steril; 2010 Mar; 93(4):1200-7. PubMed ID: 19131059
[TBL] [Abstract][Full Text] [Related]
20. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
